Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- Lululemon Has A New CEO also written by Reuters
- Exclusive: IBM hired advisers to deal with restless investors - sources also written by Reuters
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- UBS Still Needs to Get Rid of Investment Bank - Activist Investor also written by Reuters
- Germany's Corporate Governance Problem also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
Login to comment.